2022 Q4 Form 10-Q Financial Statement

#000149315222030044 Filed on November 01, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $2.670K $1.683K $950.00
YoY Change 1235.0% 77.16% -75.07%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $672.3K $6.679K $228.3K
YoY Change -22.47% -97.07% 46.0%
% of Gross Profit
Research & Development $0.00 $47.85K
YoY Change -100.0%
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change -100.0%
% of Gross Profit
Operating Expenses $685.0K $112.7K $279.3K
YoY Change -35.42% -59.66%
Operating Profit -$111.0K -$278.3K
YoY Change -60.12%
Interest Expense -$83.41K -$6.850K -$5.310K
YoY Change 299.09% 29.0% 387.16%
% of Operating Profit
Other Income/Expense, Net -$6.848K $0.00
YoY Change
Pretax Income -$979.1K -$117.8K -$285.7K
YoY Change -9.99% -58.76% -7.06%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$979.1K -$117.8K -$285.7K
YoY Change 96.86% -58.76% -7.06%
Net Earnings / Revenue -36668.54% -7001.13% -30077.68%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share -$0.01 -$1.126K -$3.780K
COMMON SHARES
Basic Shares Outstanding 115.0M shares 101.2M shares
Diluted Shares Outstanding 104.6M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.070K $38.67K $3.370K
YoY Change -92.5% 1047.48% -96.04%
Cash & Equivalents $4.067K $38.67K $3.369K
Short-Term Investments
Other Short-Term Assets $53.81K $61.52K $342.5K
YoY Change -74.4% -82.04% 48832.86%
Inventory
Prepaid Expenses
Receivables $300.00
Other Receivables $0.00
Total Short-Term Assets $57.88K $100.2K $346.2K
YoY Change -78.12% -71.06% 302.56%
LONG-TERM ASSETS
Property, Plant & Equipment $283.2K $211.8K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $283.2K $211.8K $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $57.88K $100.2K $346.2K
Total Long-Term Assets $283.2K $211.8K $0.00
Total Assets $341.1K $311.9K $346.2K
YoY Change 28.97% -9.89% -21.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $56.32K $40.04K $58.42K
YoY Change 29.29% -31.46% -43.91%
Accrued Expenses $47.74K $45.86K $21.23K
YoY Change 80.7% 116.02% 1847.71%
Deferred Revenue $0.00 $0.00
YoY Change
Short-Term Debt $185.0K $135.0K $207.5K
YoY Change -5.13% -34.94% 29.69%
Long-Term Debt Due $4.710K $2.090K
YoY Change
Total Short-Term Liabilities $293.8K $223.0K $287.2K
YoY Change 10.86% -22.34% 8.26%
LONG-TERM LIABILITIES
Long-Term Debt $30.36K $130.9K $34.90K
YoY Change -12.13% 275.04% -1.97%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $30.36K $130.9K $34.90K
YoY Change -12.12% 275.03% -1.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $293.8K $223.0K $287.2K
Total Long-Term Liabilities $30.36K $130.9K $34.90K
Total Liabilities $324.1K $353.9K $322.1K
YoY Change 8.21% 9.88% 7.05%
SHAREHOLDERS EQUITY
Retained Earnings -$7.233M -$7.028M
YoY Change 15.65%
Common Stock $119.1K $109.9K
YoY Change 43.91%
Preferred Stock
YoY Change
Treasury Stock (at cost) $50.00K $50.00K
YoY Change
Treasury Stock Shares
Shareholders Equity $16.99K -$41.93K $24.15K
YoY Change
Total Liabilities & Shareholders Equity $341.1K $311.9K $346.2K
YoY Change 28.97% -9.89% -21.03%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$979.1K -$117.8K -$285.7K
YoY Change 96.86% -58.76% -7.06%
Depreciation, Depletion And Amortization $0.00
YoY Change -100.0%
Cash From Operating Activities -$32.20K -$162.6K -$157.0K
YoY Change -86.92% 3.58% 175.62%
INVESTING ACTIVITIES
Capital Expenditures $71.48K -$75.15K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$71.48K -$75.15K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 69.08K 259.7K 62.00K
YoY Change -76.75% 318.79% -54.07%
NET CHANGE
Cash From Operating Activities -32.20K -162.6K -157.0K
Cash From Investing Activities -71.48K -75.15K 0.000
Cash From Financing Activities 69.08K 259.7K 62.00K
Net Change In Cash -34.60K 21.86K -95.02K
YoY Change -167.95% -123.01% -221.77%
FREE CASH FLOW
Cash From Operating Activities -$32.20K -$162.6K -$157.0K
Capital Expenditures $71.48K -$75.15K $0.00
Free Cash Flow -$103.7K -$87.49K -$157.0K
YoY Change -44.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001437517
dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
usd
CY2022Q3 CLOQ Common Stock Settlement Liability Current
CommonStockSettlementLiabilityCurrent
usd
CY2021Q4 CLOQ Common Stock Settlement Liability Current
CommonStockSettlementLiabilityCurrent
usd
CY2021Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
usd
CY2021Q4 CLOQ Stock Subscription Receivable
StockSubscriptionReceivable
usd
CY2022Q3 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
usd
CY2021Q3 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
usd
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2021Q3 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
usd
CY2022Q3 CLOQ Loss On Settlement Of Payables
LossOnSettlementOfPayables
usd
CLOQ Loss On Settlement Of Payables
LossOnSettlementOfPayables
usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2021Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CLOQ Loss On Settlement Of Payable
LossOnSettlementOfPayable
usd
CLOQ Loss On Settlement With Officer And Director
LossOnSettlementWithOfficerAndDirector
usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CLOQ Common Stock Issued For Accrued Expense
CommonStockIssuedForAccruedExpense
usd
CLOQ Common Stock Issued For Accounts Payable
CommonStockIssuedForAccountsPayable
usd
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
usd
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
usd
us-gaap Notes Issued1
NotesIssued1
usd
CLOQ Common Stock To Be Issued For Note Payable
CommonStockToBeIssuedForNotePayable
usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
usd
CY2022Q3 CLOQ Accumulated Impairment Expense
AccumulatedImpairmentExpense
usd
CY2021Q4 CLOQ Accumulated Impairment Expense
AccumulatedImpairmentExpense
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-170132
dei Entity Registrant Name
EntityRegistrantName
CYBERLOQ TECHNOLOGIES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity File Number
EntityFileNumber
333-170132
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2118480
dei Entity Address Address Line1
EntityAddressAddressLine1
4837 Swift Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 210-1
dei Entity Address City Or Town
EntityAddressCityOrTown
Sarasota
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
34231
dei City Area Code
CityAreaCode
612
dei Local Phone Number
LocalPhoneNumber
961-4536
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
CLOQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
115039754 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38671 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54295 usd
CY2022Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
61515 usd
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
210208 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
100186 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
264503 usd
CY2022Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
211760 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
211760 usd
CY2022Q3 us-gaap Assets
Assets
311946 usd
CY2021Q4 us-gaap Assets
Assets
264503 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
40039 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
43560 usd
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
50000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6254074 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
45864 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
26420 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
35000 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
45000 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
100000 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
150000 usd
CY2022Q3 us-gaap Loans Payable Current
LoansPayableCurrent
2088 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
222991 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
264980 usd
CY2022Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
30887 usd
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
34550 usd
CY2022Q3 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
100000 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
130887 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
34550 usd
CY2022Q3 us-gaap Liabilities
Liabilities
353878 usd
CY2021Q4 us-gaap Liabilities
Liabilities
299530 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
109889754 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
109889754 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
82754515 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
82754515 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
109890 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
82755 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
20000 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
20000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
30000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
30000 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
20 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
30 usd
CY2022Q3 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
4325000 shares
CY2021Q4 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
8200000 shares
CY2022Q3 CLOQ Shares To Be Issued
SharesToBeIssued
211686 usd
CY2021Q4 CLOQ Shares To Be Issued
SharesToBeIssued
392900 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6726602 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5743362 usd
CY2022Q3 CLOQ Stock Subscription Receivable
StockSubscriptionReceivable
-12500 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7027630 usd
CY2022Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
9726 usd
CY2021Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3064 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
11910 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-41932 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-35027 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
311946 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
264503 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1683 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
954 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3087 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
900 usd
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
131 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
34192 usd
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
153511 usd
us-gaap Professional Fees
ProfessionalFees
374589 usd
us-gaap Professional Fees
ProfessionalFees
284822 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47854 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
50009 usd
CY2022Q3 us-gaap Officers Compensation
OfficersCompensation
57000 usd
CY2021Q3 us-gaap Officers Compensation
OfficersCompensation
67500 usd
us-gaap Officers Compensation
OfficersCompensation
162000 usd
us-gaap Officers Compensation
OfficersCompensation
202500 usd
CY2022Q3 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
126 usd
us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
877 usd
us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
1766 usd
CY2022Q3 CLOQ Rent Expense
RentExpense
2298 usd
CY2021Q3 CLOQ Rent Expense
RentExpense
2189 usd
CLOQ Rent Expense
RentExpense
6819 usd
CLOQ Rent Expense
RentExpense
6842 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6679 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3508 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18316 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8236 usd
CY2022Q3 us-gaap Supplies Expense
SuppliesExpense
2643 usd
CY2021Q3 us-gaap Supplies Expense
SuppliesExpense
1635 usd
us-gaap Supplies Expense
SuppliesExpense
4918 usd
us-gaap Supplies Expense
SuppliesExpense
5783 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
9128 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
112664 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
279261 usd
us-gaap Operating Expenses
OperatingExpenses
579429 usd
us-gaap Operating Expenses
OperatingExpenses
569217 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-110981 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-278307 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-576342 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-568317 usd
CY2022Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
6848 usd
CY2021Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
5306 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
24129 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
15705 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-302921 usd
CY2021Q3 CLOQ Loss On Settlement Of Payables
LossOnSettlementOfPayables
2125 usd
CLOQ Loss On Settlement Of Payables
LossOnSettlementOfPayables
6343 usd
CLOQ Loss On Settlement With Officer
LossOnSettlementWithOfficer
18086 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-105000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
50000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6848 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7431 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-197215 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22048 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-117829 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-285738 usd
us-gaap Net Income Loss
NetIncomeLoss
-773557 usd
us-gaap Net Income Loss
NetIncomeLoss
-590365 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
104639754 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
75594515 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
95069241 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
73701182 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-310023 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20000 usd
CY2021Q1 CLOQ Subscribed Shares Value Of Common Stock
SubscribedSharesValueOfCommonStock
9218 usd
CY2021Q1 CLOQ Stock Un Issued During Period Value Stock Subscriptions
StockUnIssuedDuringPeriodValueStockSubscriptions
93000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-102653 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-290459 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
210000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
430000 usd
CY2021Q2 CLOQ Stock To Be Issued During Period Value Issued For Services
StockToBeIssuedDuringPeriodValueIssuedForServices
107500 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-201975 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
255066 usd
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50200 usd
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
4625 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-285738 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
24153 usd
CY2021Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
210000 usd
CY2021Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
35765 usd
CY2021Q4 CLOQ Stock To Be Issued During Period Value
StockToBeIssuedDuringPeriodValue
100000 usd
CY2021Q4 CLOQ Stock Issued During Period Common Stock To Be Issued For Officers Fees
StockIssuedDuringPeriodCommonStockToBeIssuedForOfficersFees
92400 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-497345 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-35027 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
97500 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
100000 usd
CY2022Q1 CLOQ Stock To Be Issued During Period Value
StockToBeIssuedDuringPeriodValue
50000 usd
CY2022Q1 CLOQ Stock Redeemed During Period Value
StockRedeemedDuringPeriodValue
540000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
22500 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-630458 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
54975 usd
CY2022Q2 CLOQ Common Stock Issued For Settlement Of Debt
CommonStockIssuedForSettlementOfDebt
140000 usd
CLOQ Proceeds From Issuance Of Commonstock To Be Issued
ProceedsFromIssuanceOfCommonstockToBeIssued
93000 usd
CY2022Q1 CLOQ Stock Issued During Period Value Preferred Stock Redeemed For Officers Settlement
StockIssuedDuringPeriodValuePreferredStockRedeemedForOfficersSettlement
10 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1575 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
52186 usd
CY2022Q2 CLOQ Retirement Of Convertible Debt
RetirementOfConvertibleDebt
50000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-352806 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
700 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
125000 usd
us-gaap Stock Issued1
StockIssued1
537500 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-686103 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-686103 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
210000 usd
CY2022Q3 CLOQ Stock To Be Issued During Period Value
StockToBeIssuedDuringPeriodValue
50000 usd
CY2022Q3 CLOQ Stock Issued During Period Common Stock To Be Issued For Officers Fees
StockIssuedDuringPeriodCommonStockToBeIssuedForOfficersFees
12000 usd
CY2022Q3 CLOQ Reversal Of Common Stock Redeemed For Officers Settlement
ReversalOfCommonStockRedeemedForOfficersSettlement
490000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-117829 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-117829 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-41932 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-41932 usd
us-gaap Net Income Loss
NetIncomeLoss
-773557 usd
us-gaap Net Income Loss
NetIncomeLoss
-590365 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
50000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
318042 usd
us-gaap Share Based Compensation
ShareBasedCompensation
198168 usd
CLOQ Loss On Settlement Of Payable
LossOnSettlementOfPayable
6343 usd
CLOQ Loss On Settlement With Officer And Director
LossOnSettlementWithOfficerAndDirector
18086 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
105000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
300 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
57349 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-21617 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-47924 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
21631 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
15706 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-339764 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-418372 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
211760 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-211760 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
412475 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
280200 usd
CLOQ Proceeds From Issuance Of Commonstock To Be Issued
ProceedsFromIssuanceOfCommonstockToBeIssued
50000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
535900 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
395000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15624 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-23372 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54295 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26741 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
38671 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3369 usd
us-gaap Stock Issued1
StockIssued1
100000 usd
CLOQ Common Stock Issued For Accrued Expense
CommonStockIssuedForAccruedExpense
5000 usd
CLOQ Common Stock Issued For Accounts Payable
CommonStockIssuedForAccountsPayable
2500 usd
us-gaap Notes Issued1
NotesIssued1
35000 usd
CLOQ Common Stock To Be Issued For Note Payable
CommonStockToBeIssuedForNotePayable
52186 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zG4kq4yZGsOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_zdJtc3lVU626">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In preparing these financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the year reported. Actual results may differ from these estimates. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0 usd
CY2021Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0 usd
CY2020 us-gaap Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
321725 usd
CY2022Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
211760 usd
CY2022Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
us-gaap Advertising Expense
AdvertisingExpense
8418 usd
us-gaap Advertising Expense
AdvertisingExpense
4420 usd
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 usd
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 usd
CY2020Q2 us-gaap Payments For Rent
PaymentsForRent
426 usd
CY2020Q2 us-gaap Payments For Deposits
PaymentsForDeposits
500 usd
CY2020Q3 us-gaap Payments For Rent
PaymentsForRent
639 usd
CY2020Q3 us-gaap Payments For Deposits
PaymentsForDeposits
200 usd
CY2021Q2 us-gaap Payments For Rent
PaymentsForRent
730 usd
CY2021Q2 us-gaap Payments For Deposits
PaymentsForDeposits
1415 usd
CY2022Q2 us-gaap Payments For Rent
PaymentsForRent
719 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
211760 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7027630 usd
us-gaap Net Income Loss
NetIncomeLoss
-773557 usd
CY2022Q1 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
10000 shares
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
10 usd
CY2022Q1 us-gaap Severance Costs1
SeveranceCosts1
50000 usd
CY2022Q1 CLOQ Gain Loss On Severance Costs
GainLossOnSeveranceCosts
18076 usd
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
500000 shares
CY2022Q1 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
50000 usd
CY2022Q1 us-gaap Litigation Reserve
LitigationReserve
490000 usd
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-540000 usd
us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
5400000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 CLOQ Stock Subscription Receivable Shares
StockSubscriptionReceivableShares
625000 shares
CY2022Q3 CLOQ Stock Subscription Receivable
StockSubscriptionReceivable
-12500 usd
CY2022Q3 CLOQ Number Of Shares Issued For Officers Fees
NumberOfSharesIssuedForOfficersFees
100000 shares
CY2021Q3 CLOQ Stock Issued During Period Shares Commonstock
StockIssuedDuringPeriodSharesCommonstock
25000 shares
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
500000 shares
CY2022Q1 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
50000 usd
CY2022Q1 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
10000 shares
CY2020Q2 us-gaap Payments For Rent
PaymentsForRent
426 usd
CY2020Q2 us-gaap Payments For Deposits
PaymentsForDeposits
500 usd
CY2020Q2 us-gaap Payments For Rent
PaymentsForRent
426 usd
CY2020Q3 us-gaap Payments For Rent
PaymentsForRent
639 usd
CY2020Q3 us-gaap Payments For Deposits
PaymentsForDeposits
200 usd
CY2022Q2 us-gaap Payments For Rent
PaymentsForRent
719 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
35000 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
45000 usd
CY2022Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
200000 usd
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
150000 usd

Files In Submission

Name View Source Status
0001493152-22-030044-index-headers.html Edgar Link pending
0001493152-22-030044-index.html Edgar Link pending
0001493152-22-030044.txt Edgar Link pending
0001493152-22-030044-xbrl.zip Edgar Link pending
cloq-20220930.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
cloq-20220930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cloq-20220930_pre.xml Edgar Link unprocessable
cloq-20220930_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cloq-20220930_def.xml Edgar Link unprocessable